You are here

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

BT_20171005_ABBVIE_3116816.jpg
(From far left): Site director Marc O'Donoghue, chairman of the Singapore Economic Development Board Beh Swan Gin, Trade and Industry Minister S Iswaran, chairman and chief executive of AbbVie Richard Gonzalez, senior vice-president of operations at AbbVie Azita Saleki-Gerhardt and vice-president of manufacturing operations Biologic at AbbVie Daniela Ottini.

Singapore

GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial...

sentifi.com

Market voices on: